NYSE:PRGOPharmaceuticals
Perrigo (PRGO) Stock Reprices Fast As Profit Returns Meet Margin Pressure
Perrigo just rose 23.1% in a single session, which indicates sentiment shifted far faster than the underlying story changed. The stock entered this report trading on a low trailing price-to-sales ratio of 0.4x, far below the broader pharmaceuticals group, and investors finally treated that discount as more than background noise.
The main focus is profit tone, not revenue. After a string of heavy losses, Perrigo posted Q2 basic earnings per share of US$0.64, and net income from continuing...